HETRONIFLY 10 mg/ml concentrate for solution for infusion
Product Brand Name: HETRONIFLY. API Name: Serplulimab. It is used to treat adults with extensive-stage small cell lung cancer (ES-SCLC).
HETRONIFLY in combination with carboplatin and etoposide is indicated for the first-line treatment
of adult patients with extensive-stage small cell lung cancer (ES-SCLC). Intas Pharmaceuticals has launched HETRONIFLY™ (Serplulimab), the first PD-1 inhibitor globally approved for the treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC), in the Indian market.
Generic name: HETRONIFLY
Brand name: Serplulimab
Dosage form: 10 mg/ml concentrate for solution for infusion.
Therapeutic area (MeSH): Small Cell Lung Carcinoma
Manufactured by Shanghai Henlius Biotech.
For Best Price: To know the best price of the product available with Lucknow Speciality Pharma call at Contact No. M: 9336559090 or WhatsApp at 9336559090 or email us at info@lucknowpharma.com
Disclaimer: All Trademarks and Brands that appear on the website belong to their respective owners and Lucknow Speciality Pharma (www.lucknowpharma.com) does not lay any claim on them we only provide Information.
About Us
Lucknow Speciality Pharma is dedicated to delivering life-changing healthcare solutions. As a trusted wholesale supplier of specialized medicines, we cater to critical care areas such as oncology, nephrology, and rare diseases. Our patient-centric approach also includes personalized catering services, ensuring that patients receive the care, support, and nutrition they need to thrive. We also extend our services globally, welcoming international patients and buyers who seek our expertise and high-quality products.
Lucknow Speciality Pharma is a registered Pharmaceutical Firm in Lucknow, India. Registered under GST Act. Registration Number : 09AAOPG3102HIZY. It provide assistance and connectivity with drug pharmacies or distributors for access to genuine medicines at competitive prices.
Get Access To HETRONIFLY 10 mg/ml concentrate for solution for infusion
Enter Buying Requirements Details
For precise quotations, kindly ensure your requirements include the product name, order quantity, intended usage, and any special requests you may have.
Branch Offices in India : Lucknow | Agra | Varanasi | Gorakhpur | Kanpur | Indore | Patna | Kolkata | Nepal
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 20 June 2025, approved serplulimab (Hetronifly) to treat adults with extensive-stage small cell lung cancer (ES-SCLC), which has not previously been treated, and has spread within the lungs or to other parts of the body.
SCLC is a fast-growing cancer that typically develops in the airways of the lungs. It accounts for 10-15% of lung cancer cases and is often diagnosed at a late stage when the cancer has already spread.
Serplulimab is a monoclonal antibody (a targeted therapy) that supports the immune system by blocking PD-1, a receptor some cancer cells use to avoid detection. By inhibiting PD-1, it helps immune cells recognise and destroy cancer cells more effectively.
Serplulimab is available in India on request-
Lucknow Speciality Pharma is the leading Pharma brand and one of the most leading Pharma Wholesalers in Lucknow. We are expanding our reach across India. To get “HETRONIFLY (Serplulimab) Injection in India“, patients can simply fill the order form or, please call us at 9811747774, 9555306364 or WhatsApp at 9555306364, 9555306364 or email us at info@lucknowpharma.com. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
NEWS / UPDATES
- Intas Pharmaceuticals Launches HETRONIFLY™ (Serplulimab), India's First Novel Immunotherapy for Advanced Small Cell Lung Cancer.
- [European Medicines Agency (EMA). Medicines. Hetronifly. [cited 2024-11-18]. Available from:
https://www.ema.europa.eu/en/medicines/human/EPAR/hetronifly. - Statistik Austria. Krebserkrankungen. Krebsinzidenz nach ausgewählten Lokalisationen und Geschlecht. [cited 2024-11-18]. Available from:
https://www.statistik.at/statistiken/bevoelkerung-und-soziales/gesundheit/krebserkrankungen. - Onkopedia, Wolf M and et al. Onkopedia guidelines. Small-Cell Lung Cancer (SCLC). [cited 2024-11-18]. Available from: https://www.onkopediaguidelines.info/en/onkopedia/guidelines/small-cell-lung-cancer-sclc/@@guideline/html/index.html#ID0E5DBG.
- U.S. Food and Drug Administration (FDA). Orphan Drug Designations and Approvals. [cited 2024-11-18]. Available from:
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=869822.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 AM and 7:00 PM IST.
Landline :
05226180025
Mobile :
+91 93365 59090
WhatsApp:
+91-9760014849
Email:
info@lucknowpharma.com
For Hospitals and Clinics:
“Hospitals and clinics in Lucknow can now avail exclusive discounts on bulk medicine orders. Lucknow Speciality Pharma offers the best pharmaceutical deals—call us today to get updated offers on minimum order quantities!”
For Retail Customers:
“Looking for affordable medicines in Lucknow? Lucknow Speciality Pharma offers special discounts on a wide range of medicines. Call now to discover our latest offers available with a minimum purchase!”
